Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: BMS-690514|DRUG: Lapatinib|DRUG: Letrozole
Sponsor: Bristol-Myers Squibb